Clario, a Nordic Capital and Astorg-backed software provider for clinical trials, confidentially filed for an IPO, Bloomberg reports, citing sources familiar.
Why it matters: Clario is reportedly targeting a $10 billion-plus valuation as the health care IPO market starts to warm up.
